£795.00

The 2023-2028 World Outlook for Dysphagia Management Drugs

Subjects

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days · 91 data points

Historical

Generating forecast…

Price Distribution

Price distribution over 91 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (91 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 91 days

Description

This study covers the world outlook for dysphagia management drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of dysphagia management drugs as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AstraZeneca, BARD, A Becton, Dickinson Company, Cipla, Cook Medical, Eisai Company, Kent Precision Foods Group, Nestle Health Science, and Nutricia. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B09XZMCMY3
Category: Books > Subjects
Domain: Amazon UK
Release Date: 10 May 2022
Listed Since: 25 April 2022

The 2023-2028 World Outlook for Dysphagia Management Drugs

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 Outlook for Dysphagia Management Drugs in India

The 2023-2028 Outlook for Dysphagia Management Drugs in the United States

The 2023-2028 Outlook for Dysphagia Management Drugs in China

The 2023-2028 Outlook for Dysphagia Management Drugs in Japan

The 2025-2030 World Outlook for Dysphagia Management Drugs

The 2023-2028 Outlook for Dysphagia Management Drugs for US Zip Codes

The 2023-2028 World Outlook for Powder-Thickening Dysphagia Supplements

Dysphagia in Adults and Children, An Issue of Otolaryngologic Clinics of North America: Volume 57-4 (The Clinics: Surgery, Volume 57-4)

Plural Publishing Dysphagia Assessment and Treatment Planning

Dysphagia Management in Head and Neck Cancers: A Manual and Atlas

Neuroscientific Principles of Swallowing and Dysphagia (Dysphagia Series)

Dysphagia: Foundation, Theory and Practice

The 2025-2030 World Outlook for Esophagus-Targeting Smart Pills

Dysphagia: Diagnosis and Treatment (Medical Radiology)

Navigating Swallowing Disorders - From Symptoms to Solutions

Dysphagia: Diagnosis and Treatment (Medical Radiology)

Working with Dysphagia

Working with Communication and Swallowing Difficulties in Older Adults

Manual of Diagnostic and Therapeutic Techniques for Disorders of Deglutition

Clinical Management of Swallowing Disorders

Dysphagia: A Clinical Guide

Evaluation and Management of Dysphagia: An Evidence-Based Approach

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States

Swallowing Disorders